PIGLIASCO, FEDERICA
PIGLIASCO, FEDERICA
100009 - Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili
"Standard" Is More Than Enough: Therapeutic Drug Monitoring Confirms Early Target Attainment of Teicoplanin Regimens in Pediatric Patients.
2026-01-01 Mariani, M; Cafaro, A; Orsi, Sm; Baiardi, G; Barco, S; Pigliasco, F; Ricci, E; Saffioti, C; Bandettini, R; Mesini, A; Mattioli, F; Moscatelli, A; Cangemi, G; Castagnola, E
A Novel LC-MS/MS Method for the Measurement of Elexacaftor, Tezacaftor and Ivacaftor in Plasma, Dried Plasma Spot (DPS) and Whole Blood in Volumetric Absorptive Microsampling (VAMS) Devices
2025-01-01 Pigliasco, F.; Cafaro, A.; Barco, S.; Cresta, F.; Casciaro, R.; Pedemonte, N.; Mattioli, F.; Castellani, C.; Cangemi, G.
A Novel LC-MS/MS Method for Therapeutic Drug Monitoring of Baricitinib in Plasma of Pediatric Patients
2024-01-01 Cafaro, Alessia; Baiardi, Giammarco; Pigliasco, Federica; Barco, Sebastiano; Mattioli, Francesca; Volpi, Stefano; Caorsi, Roberta; Gattorno, Marco; Cangemi, Giuliana
A novel LC–MS/MS-based method for the diagnosis of ADA2 deficiency from dried plasma spot
2021-01-01 Cafaro, A.; Pigliasco, F.; Barco, S.; Penco, F.; Schena, F.; Caorsi, R.; Volpi, S.; Tripodi, G.; Gattorno, M.; Cangemi, G.
A VAMS-based LC-MS/MS method for precise cenobamate quantification in epilepsy (patients)
2024-01-01 Pigliasco, F; Cafaro, A; Barco, S; Biondi, M; Stella, M; Mattioli, F; Riva, A; De Grazia, U; Molteni, L; Micalizzi, E; Villani, F; Striano, P; Bandettini, R; Cangemi, G
Accidental cannabis intoxication in two young children: clinical presentation and toxicokinetics - a case series
2025-01-01 Cafaro, A; Pigliasco, F; Barco, S; Negro, I; Piccotti, E; Manfredini, L; Mahameed, S; Bandettini, R; Debbia, C; Mattioli, F; Cangemi, G
Cannabidiol, ∆9-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients
2022-01-01 Pigliasco, F.; Malaca, S.; Lo Faro, A. F.; Tini, A.; Cangemi, G.; Cafaro, A.; Barco, S.; Riva, A.; Pisati, A.; Amadori, E.; Striano, P.; Tagliabracci, A.; Huestis, M. A.; Busardo, F. P.
Development and Validation of a Novel LC-MS/MS Method for a TDM-Guided Personalization of HSCT Conditioning with High-Dose Busulfan in Children
2023-01-01 Cafaro, Alessia; Pigliasco, Federica; Baiardi, Giammarco; Barco, Sebastiano; Stella, Manuela; Bandettini, Roberto; Mattioli, Francesca; Faraci, Maura; Cangemi, Giuliana
Diagnostic workflow for Adenosine Deaminase-2 Deficiency (DADA2): a proposal
2025-01-01 Cafaro, Alessia; Grossi, Alice; Barco, Sebastiano; Pigliasco, Federica; Biondi, Margherita; Schena, Francesca; Penco, Federica; Signa, Sara; Drago, Enrico; Matucci-Cerinic, Caterina; Volpi, Stefano; Caorsi, Roberta; Bandettini, Roberto; Ceccherini, Isabella; Gattorno, Marco; Cangemi, Giuliana
Dried plasma spot as an innovative approach to therapeutic drug monitoring of apixaban: Development and validation of a novel liquid chromatography-tandem mass spectrometry method
2024-01-01 Cafaro, A; Stella, M; Baiardi, G; Barco, S; Pigliasco, F; Bandettini, R; Nanni, L; Mattioli, F; Cangemi, G
Indications for the harmonization of the therapeutic intervals of antibacterial drugs|Indicazioni per l'armonizzazione degli intervalli terapeutici dei farmaci antibatterici
2022-01-01 Cangemi, G.; Barbagallo, L.; Cafaro, A.; Pigliasco, F.; Maria, Goffredo; Di Paolo, A.
Innovative LC-MS/MS method for therapeutic drug monitoring of fenfluramine and cannabidiol in the plasma of pediatric patients with epilepsy
2024-01-01 Pigliasco, F; Cafaro, A; Barco, S; Stella, M; Mattioli, F; Riva, A; Mancardi, Mm; Lattanzi, S; Bandettini, R; Striano, P; Cangemi, G
Liquid Chromatography-Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Dalbavancin in Plasma of Pediatric and Young Adult Patients
2024-01-01 Cafaro, A; Mariani, M; Pigliasco, F; Baiardi, G; Barco, S; Biondi, M; Mesini, A; Russo, C; Saffioti, C; Mattioli, F; Castagnola, E; Cangemi, G
Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method
2023-01-01 Pigliasco, Federica; Cafaro, Alessia; Stella, Manuela; Baiardi, Giammarco; Barco, Sebastiano; Pedemonte, Nicoletta; D'Orsi, Claudia; Cresta, Federico; Casciaro, Rosaria; Castellani, Carlo; Grazia Calevo, Maria; Mattioli, Francesca; Cangemi, Giuliana
Therapeutic drug monitoring of medical cannabis in pediatrics: The experience of Giannina Gaslini Institute Il monitoraggio terapeutico della Cannabis medica nei pazienti pediatrici: l’esperienza dell’Istituto Giannina Gaslini
2023-01-01 Cafaro, A.; Pigliasco, F.; Barco, S.; Riva, A.; Striano, P.; Manfredini, L.; Barabino, P.; Mattioli, F.; Pichini, S.; Busardo, F. P.; Cangemi, G.
Therapeutic monitoring of Ivacaftor, Tezacaftor and Elexacaftor in patients with cystic fibrosis|Monitoraggio terapeutico di Ivacaftor, Tezacaftor e Elexacaftor in pazienti con fibrosi cistica
2023-01-01 Pigliasco, F.; Barco, S.; Pedemonte, N.; Cresta, F.; Casciaro, R.; Castellani, C.; Barbagallo, L.; Maffia, A.; Cangemi, G.; Cafaro, A.
UHPLC-MS/MS analysis of cannabidiol and its metabolites in serum of patients with resistant epilepsy treated with CBD formulations
2021-01-01 Malaca, S.; Gottardi, M.; Pigliasco, F.; Barco, S.; Cafaro, A.; Amadori, E.; Riva, A.; Marcenaro, M.; Striano, P.; Cangemi, G.; Pacifici, R.; Pichini, S.; Busardo, F. P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Standard" Is More Than Enough: Therapeutic Drug Monitoring Confirms Early Target Attainment of Teicoplanin Regimens in Pediatric Patients. | 1-gen-2026 | Mariani, M; Cafaro, A; Orsi, Sm; Baiardi, G; Barco, S; Pigliasco, F; Ricci, E; Saffioti, C; Bandettini, R; Mesini, A; Mattioli, F; Moscatelli, A; Cangemi, G; Castagnola, E | |
| A Novel LC-MS/MS Method for the Measurement of Elexacaftor, Tezacaftor and Ivacaftor in Plasma, Dried Plasma Spot (DPS) and Whole Blood in Volumetric Absorptive Microsampling (VAMS) Devices | 1-gen-2025 | Pigliasco, F.; Cafaro, A.; Barco, S.; Cresta, F.; Casciaro, R.; Pedemonte, N.; Mattioli, F.; Castellani, C.; Cangemi, G. | |
| A Novel LC-MS/MS Method for Therapeutic Drug Monitoring of Baricitinib in Plasma of Pediatric Patients | 1-gen-2024 | Cafaro, Alessia; Baiardi, Giammarco; Pigliasco, Federica; Barco, Sebastiano; Mattioli, Francesca; Volpi, Stefano; Caorsi, Roberta; Gattorno, Marco; Cangemi, Giuliana | |
| A novel LC–MS/MS-based method for the diagnosis of ADA2 deficiency from dried plasma spot | 1-gen-2021 | Cafaro, A.; Pigliasco, F.; Barco, S.; Penco, F.; Schena, F.; Caorsi, R.; Volpi, S.; Tripodi, G.; Gattorno, M.; Cangemi, G. | |
| A VAMS-based LC-MS/MS method for precise cenobamate quantification in epilepsy (patients) | 1-gen-2024 | Pigliasco, F; Cafaro, A; Barco, S; Biondi, M; Stella, M; Mattioli, F; Riva, A; De Grazia, U; Molteni, L; Micalizzi, E; Villani, F; Striano, P; Bandettini, R; Cangemi, G | |
| Accidental cannabis intoxication in two young children: clinical presentation and toxicokinetics - a case series | 1-gen-2025 | Cafaro, A; Pigliasco, F; Barco, S; Negro, I; Piccotti, E; Manfredini, L; Mahameed, S; Bandettini, R; Debbia, C; Mattioli, F; Cangemi, G | |
| Cannabidiol, ∆9-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients | 1-gen-2022 | Pigliasco, F.; Malaca, S.; Lo Faro, A. F.; Tini, A.; Cangemi, G.; Cafaro, A.; Barco, S.; Riva, A.; Pisati, A.; Amadori, E.; Striano, P.; Tagliabracci, A.; Huestis, M. A.; Busardo, F. P. | |
| Development and Validation of a Novel LC-MS/MS Method for a TDM-Guided Personalization of HSCT Conditioning with High-Dose Busulfan in Children | 1-gen-2023 | Cafaro, Alessia; Pigliasco, Federica; Baiardi, Giammarco; Barco, Sebastiano; Stella, Manuela; Bandettini, Roberto; Mattioli, Francesca; Faraci, Maura; Cangemi, Giuliana | |
| Diagnostic workflow for Adenosine Deaminase-2 Deficiency (DADA2): a proposal | 1-gen-2025 | Cafaro, Alessia; Grossi, Alice; Barco, Sebastiano; Pigliasco, Federica; Biondi, Margherita; Schena, Francesca; Penco, Federica; Signa, Sara; Drago, Enrico; Matucci-Cerinic, Caterina; Volpi, Stefano; Caorsi, Roberta; Bandettini, Roberto; Ceccherini, Isabella; Gattorno, Marco; Cangemi, Giuliana | |
| Dried plasma spot as an innovative approach to therapeutic drug monitoring of apixaban: Development and validation of a novel liquid chromatography-tandem mass spectrometry method | 1-gen-2024 | Cafaro, A; Stella, M; Baiardi, G; Barco, S; Pigliasco, F; Bandettini, R; Nanni, L; Mattioli, F; Cangemi, G | |
| Indications for the harmonization of the therapeutic intervals of antibacterial drugs|Indicazioni per l'armonizzazione degli intervalli terapeutici dei farmaci antibatterici | 1-gen-2022 | Cangemi, G.; Barbagallo, L.; Cafaro, A.; Pigliasco, F.; Maria, Goffredo; Di Paolo, A. | |
| Innovative LC-MS/MS method for therapeutic drug monitoring of fenfluramine and cannabidiol in the plasma of pediatric patients with epilepsy | 1-gen-2024 | Pigliasco, F; Cafaro, A; Barco, S; Stella, M; Mattioli, F; Riva, A; Mancardi, Mm; Lattanzi, S; Bandettini, R; Striano, P; Cangemi, G | |
| Liquid Chromatography-Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Dalbavancin in Plasma of Pediatric and Young Adult Patients | 1-gen-2024 | Cafaro, A; Mariani, M; Pigliasco, F; Baiardi, G; Barco, S; Biondi, M; Mesini, A; Russo, C; Saffioti, C; Mattioli, F; Castagnola, E; Cangemi, G | |
| Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method | 1-gen-2023 | Pigliasco, Federica; Cafaro, Alessia; Stella, Manuela; Baiardi, Giammarco; Barco, Sebastiano; Pedemonte, Nicoletta; D'Orsi, Claudia; Cresta, Federico; Casciaro, Rosaria; Castellani, Carlo; Grazia Calevo, Maria; Mattioli, Francesca; Cangemi, Giuliana | |
| Therapeutic drug monitoring of medical cannabis in pediatrics: The experience of Giannina Gaslini Institute Il monitoraggio terapeutico della Cannabis medica nei pazienti pediatrici: l’esperienza dell’Istituto Giannina Gaslini | 1-gen-2023 | Cafaro, A.; Pigliasco, F.; Barco, S.; Riva, A.; Striano, P.; Manfredini, L.; Barabino, P.; Mattioli, F.; Pichini, S.; Busardo, F. P.; Cangemi, G. | |
| Therapeutic monitoring of Ivacaftor, Tezacaftor and Elexacaftor in patients with cystic fibrosis|Monitoraggio terapeutico di Ivacaftor, Tezacaftor e Elexacaftor in pazienti con fibrosi cistica | 1-gen-2023 | Pigliasco, F.; Barco, S.; Pedemonte, N.; Cresta, F.; Casciaro, R.; Castellani, C.; Barbagallo, L.; Maffia, A.; Cangemi, G.; Cafaro, A. | |
| UHPLC-MS/MS analysis of cannabidiol and its metabolites in serum of patients with resistant epilepsy treated with CBD formulations | 1-gen-2021 | Malaca, S.; Gottardi, M.; Pigliasco, F.; Barco, S.; Cafaro, A.; Amadori, E.; Riva, A.; Marcenaro, M.; Striano, P.; Cangemi, G.; Pacifici, R.; Pichini, S.; Busardo, F. P. |